ArticleAAPS PharmSciTech2026
Managing Dissolved Air Throughout Freeze-Thaw Process to Reduce Aggregation of Human Serum Albumin.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Freeze-thaw (FT) stress compromises protein stability through ice crystal formation and exposure to air-liquid and ice-liquid interfaces. This study investigated whether deaeration could mitigate Human Serum Albumin (HSA) aggregation by limiting gas-mediated interfacial stress. Tween 80 and trehalose were included to evaluate deaeration efficiency in the presence of common formulation components. The study demonstrated that deaeration using either PTFE or glass stirring consistently reduced dissolved oxygen (DO) from ~ 85% to ~ 20%, and that the extent of gas removal was independent of Tween 80 or trehalose concentration. SEC-HPLC analysis confirmed > 94% HSA monomer retention, with minimal loss attributable to deaeration. Most importantly, subvisible particles exhibited by microflow imaging (MFI) revealed the protective effect of dissolved gas reduction, with deaerated samples consistently showing lower aggregation (~ 1000 to ~ 2500 particles/mL) compared to untreated HSA samples with higher aggregation (~ 2000 to ~ 6500 particles/mL) following freezing at -80ºC. Crucially, thawing the protein samples under vacuum to prevent air redissolution preserved low dissolved air content through five FT cycles, resulting in lower aggregation than samples thawed at atmospheric pressure. The combination of deaeration process and thawing under vacuum serve as a holistic engineering approach to manage dissolved air content in protein solution and reduce the overall freeze-induced stress on HSA protein formulations.
Indexed as
Identifiers
42120633What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.